Latest Thrombus Stories

CHOP research could improve survival of those injured in war, traumaIn a finding that may potentially improve survival from war injuries and disasters, laboratory researchers report that refrigerated whole blood may have a shelf life well beyond the current standard of 24 to 48 hours."We have found that whole blood retains its clotting properties at least 11 days under standard refrigeration," said the study leader, David Jobes, M.D., a cardiothoracic anesthesiologist in the Cardiac...

RIDGEFIELD, Conn., Feb. 15, 2011 /PRNewswire/ -- Pradaxa® (dabigatran etexilate mesylate) capsules is now recommended as an alternative to warfarin to reduce the risk of stroke and blood clots in patients with non-valvular atrial fibrillation (NVAF) in the Guidelines on the Management of Patients With Atrial Fibrillation, which were jointly developed by the American College of Cardiology Foundation (ACCF), American Heart Association (AHA) and Heart Rhythm Society (HRS).(1) The...

American College of Cardiology/American Heart Association /Heart Rhythm Society GuidelinesStatement Highlights:    * A new anti-clotting drug, dabigatran, is added to recommendations for treating atrial fibrillation.    * Dabigatran is an alternative to the anti-clotting drug warfarin.    * Previous recommendations for warfarin still stand. 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran)The newly...

American Stroke Association meeting reportA new anti-clotting agent is vastly superior to aspirin at reducing stroke risk (1.6 percent per year versus 3.6 percent per year) in atrial fibrillation (AF) patients unable to take stronger drugs, according to final data reported today at the American Stroke Association's International Stroke Conference 2011. Researchers found the drug also works better in people with a history of stroke or a warning stroke.Atrial fibrillation is a heartbeat...

The enzyme that makes fireflies glow is lighting up the scientific path toward a long-sought new medical imaging agent to better monitor treatment with heparin, the blood thinner that millions of people take to prevent or treat blood clots, scientists are reporting. Their study appears in the ACS' monthly journal Bioconjugate Chemistry.Bruce Branchini and colleagues describe a need for new medical imaging agents that emit near-infrared light "” the light rays that "night vision"...

MOUNTAIN VIEW, Calif., Feb. 9, 2011 /PRNewswire/ -- Concentric Medical, Inc. today announced that the first patients were enrolled in TREVO 2 (Thrombectomy REvascularization of large Vessel Occlusions) at Oregon Health & Science University in Portland, Oregon and at Capital Health in Trenton, New Jersey. Oregon Health & Science enrolled the first patient in TREVO 2 and Capital Health was first to use the Trevo device. TREVO 2 is a pivotal clinical trial investigating the safety and...

Statement Highlights: - The American Heart Association has issued its first recommendations on treating cerebral venous thrombosis (CVT), an uncommon and frequently unrecognized type of stroke that affects about five people per million annually. - About 2 percent of pregnancy-associated strokes are attributed( )to CVT. - Use of oral contraceptives is associated with an increased risk of CVT, especially among women with an inherited blood-clotting factor. DALLAS, Feb. 3, 2011...

For almost two decades, cardiologists have searched for ways to see dangerous blood clots before they cause heart attacks.Now, researchers at Washington University School of Medicine in St. Louis report that they have designed nanoparticles that find clots and make them visible to a new kind of X-ray technology.According to Gregory Lanza, MD, PhD, a Washington University cardiologist at Barnes-Jewish Hospital, these nanoparticles will take the guesswork out of deciding whether a person coming...

Patients undergoing liver surgery have long been considered to be at low risk of venous thromboembolism. However, pulmonary embolism has recently emerged as an increasingly frequent and potentially fatal complication following liver resections.A research article published on January 21, 2011 in the World Journal of Gastroenterology addresses this question. The authors shed a new light on this discrepancy by reporting two patients who developed thrombi in their hepatic veins following...

MOUNTAIN VIEW, Calif., Jan. 26, 2011 /PRNewswire/ -- Marking a major milestone toward expanding the use of Stentriever(TM) technology for stroke patients, Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced that the first cases have been performed using its Trevo(TM) System in Canada. The Trevo System is an innovative, high-performing, easy-to-use system that utilizes Stentriever technology for the removal of clots that cause stroke. The Trevo...